This_company,_together_with its_subsidiaries, is engaged in producing and distributing research - grade antibodies and associated protein research tools worldwide. It was_founded in DATE at the ORGANIZATION ORGANIZATION ORGANIZATION, where TITLE TITLE PERSON_PERSON was working as a post-doctoral TITLE studying the newly discovered CAUSE_OF_DEATH_CAUSE_OF_DEATH protein BRCA2 in TITLE PERSON_PERSON ' laboratory. It is headquartered in CITY, the COUNTRY COUNTRY. The company primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-colour selectors, kits, loading controls, lysates, peptides, proteins, slides, tags, and cell markers, as_well_as tools and reagents. Its_products_are used in the areas of CAUSE_OF_DEATH, cardiovascular, cell biology, developmental biology, epigenetics and nuclear signalling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells, as_well_as in drug_discovery products and services. The company also engages in sales and distribution, financing, and investing activities, as_well_as selling its products online. It offers validated antibodies, other binders, and assays to the research and clinical communities to_help advance the understanding of biology and the causes of CAUSE_OF_DEATH. The company 's_mission is to_build the largest on - line catalogue of the best antibodies in the world. Its_products_are distributed in LOCATION, LOCATION COUNTRY, LOCATION COUNTRY, the LOCATION_LOCATION, LOCATION, COUNTRY, and CITY.